Imamura M, Asano S, Harada M, Ikeda Y, Kato K, Kato S, Kawa K, Kojima S, Morishima Y, Morishita Y, Nakahata T, Okamura J, Okamoto S, Shiobara S, Tanimoto M, Tsuchida M, Atsuta Y, Yamamoto K, Tanaka J, Hamajima N, Kodera Y.: Current status of hematopoietic cell transplantation for adult patients with hematologic diseases and solid tumors in Japan. Int J Hematol. 2006 Feb; 83(2): 164-178
英文原著
Miura Y, Takana J, Toubai T, Tsutsumi Y, Kato N, Hirate D, Kaji M, Sugita J, Shigematsu A, Iwao N, Ota S, Masauzi N, Fukuhara T, Kasai M, Asaka M, Imamura M.: Analysis of donor-type chimerism in lineage-specific cell populations after allogeneic myeloablative and nonmyeloablative stem cell transplantation. Bone Marrow Transplant. 2006 May; 37(9)： 837-843
Toubai T, Tanaka J, Nishihira J, Ohkawara T, Hirate D, Kondo N, Tone S, Shono Y, Ibata M, Sugita J, Kato N, Miura Y, Iwao N, Ota S, Imamura M.: Effect of macrophage migration inhibitory factor (MIF) on acute graft-versus-host disease in a murine model of allogeneic stem cell transplantation. Transpl Immunol. 2006 Aug; 16(2): 117-124
Toubai T, Tanaka J, Ota S, Fukuhara T, Hashino S, Kondo T, Shono Y, Morioka M, Kawamura T, Masauzi N, Kakinoki Y, Kobayashi H, Kunieda Y, Kasai M, Kurosawa M, Asaka M, Imamura M.: Effect of granulocyte colony-stimulating factor on IL-12 p40 production during chemotherapy for B-cell lineage non-Hodgkin's lymphoma patients. Eur J Haematol. 2006 Nov; 77(5): 403-409
Ota S, Musashi M, Kondo K, Toyoshima N, Toubai T, Onozawa M, Mori A, Hashino S, Tanaka J, Matsuno K, Imamura M, Asaka M: Effect of imatinib mesylate combined with granulocyte colony-stimulating factor on leukemic blast cells derived from advanced-stage chronic myelogeneous leukaemia patients. Acta Haematol 2006 116(1): 8-18
Onozawa M, Hashino S, Takahata M, Fujisawa F, Kawamura T, Nakagawa M, Kahata K, Kondo T, Ota S, Tanaka J, Imamura M, Asaka M: Relationship between preexisting anti-Varicella Zoster virus (VZV) antibody and clinical VZV reactivation in hematopoietic stem cell transplantation recipients. J Clin Microbiol. 2006 Dec; 44(12): 4441-4443
Nishio M, Fujimoto K, Yamamoto S, Endo T, Sakai T, Obara M, Kumano K, Minauchi K, Yamaguchi K, Takeda Y, Sato N, Koizumi K, Mukai M, Koike T: Hypogammaglobulinemia with a selective delayed recovery in memory B cells and an impaired isotype expression after rituximab administration as an adjuvant to autologous stem cell transplantation for non-Hodgkin lymphoma. Eur J Haematol. 2006 Sep; 77(3): 226-232
Fujimoto H, Onishi N, Kato N, Takekawa M, Xu XZ, Kosugi A, Kondo T, Imamura M, Oishi I, Yoda A and Minami Y: Regulation of the antioncogenic Chk2 kinase by the oncogenic Wip1 phosphatase. Cell Death Differ. 2006 Jul; 13(7): 1170-1180
Yoda A, Xu XZ, Onishi N, Toyoshima K, Fujimoto H, Kato N, Oishi I, Kondo T and Minami Y: Intrinsic kinase activity and SQ/TQ domain of Chk2 kinase as well as N-terminal domain of Wip1 phosphatase are required for regulation of Chk2 by Wip1. J Biol Chem. 2006 Aug 25; 281(34): 24847-24862
英文症例報告
Shigematsu A, Okada K, Abe N, Ota S, Kato N, Kondo K, Hige S, Tanaka J, Asaka M, Imamura M.: Non-alcoholic steatohepatitis occurring in a patient with T-lymphoblastic lymphoma during chemotherapy including prednisolone. Leuk Lymphoma. 2006 Jul; 47(7): 1397-1399
Shono Y, Toubai T, Ota S, Ibata M, Mashiko S, Hirate D, Miura Y, Umehara S, Toyoshima N, Tanaka J, Asaka M, Imamura M.: Abnormal expansion of naive B lymphocytes after unrelated cord blood transplantation - a case report. Clin Lab Haematol. 2006 Oct; 28(5): 351-354
Hashino S, Fujisawa F, Kondo T, Imamura M, Sato K, Torimoto Y, Kohgo Y, Kimura K, Furukawa H, Todo S, Asaka M: Donor-type myelodysplastic syndrome with t(2;3) and monosomy 7 after allogeneic peripheral blood stem cell transplantation and liver transplantation in a patient with severe-type aplastic anemia. Int J Hematol 2006 Nov; 84(4): 363-366
Hashimoto T, Nishio M, Sakai T, Fujimoto K, Sato N, Endo T, Koike T: Acute schizophrenic symptoms as the initial manifestation of HIV infection that respond to highly active antiretroviral therapy. Clin Infect Dis. 2006 Jun 1; 42(11): 1653-1655
